<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003051.pub3" GROUP_ID="LUNGCA" ID="409504121308310012" MERGED_FROM="" MODIFIED="2010-01-14 09:00:57 +0100" MODIFIED_BY="Sera Tort" REVIEW_NO="" REVMAN_SUB_VERSION="5.0.23" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2010-01-14 09:00:57 +0100" MODIFIED_BY="Sera Tort">
<TITLE MODIFIED="2009-03-03 01:25:20 +0100" MODIFIED_BY="[Empty name]">Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer</TITLE>
<CONTACT MODIFIED="2010-01-14 09:00:57 +0100" MODIFIED_BY="Sera Tort"><PERSON ID="8551" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>José</FIRST_NAME><LAST_NAME>Belda-Sanchís</LAST_NAME><EMAIL_1>27685jbs@comb.es</EMAIL_1><ADDRESS><DEPARTMENT>Cirugia Torácica</DEPARTMENT><ORGANISATION>Hospital Universitario Mutua de Terrassa</ORGANISATION><ADDRESS_1>Plaza Dr. Robert, 5</ADDRESS_1><CITY>Terrassa (Barcelona)</CITY><ZIP>08221</ZIP><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34937365050</PHONE_1><FAX_1>+34937365059</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-01-14 09:00:57 +0100" MODIFIED_BY="Sera Tort"><PERSON ID="8551" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>José</FIRST_NAME><LAST_NAME>Belda-Sanchís</LAST_NAME><EMAIL_1>27685jbs@comb.es</EMAIL_1><ADDRESS><DEPARTMENT>Cirugia Torácica</DEPARTMENT><ORGANISATION>Hospital Universitario Mutua de Terrassa</ORGANISATION><ADDRESS_1>Plaza Dr. Robert, 5</ADDRESS_1><CITY>Terrassa (Barcelona)</CITY><ZIP>08221</ZIP><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34937365050</PHONE_1><FAX_1>+34937365059</FAX_1></ADDRESS></PERSON><PERSON ID="8EE05FFC82E26AA201E6E48B68C63A0F" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mireia</FIRST_NAME><LAST_NAME>Serra-Mitjans</LAST_NAME><POSITION>Attending in Thoracic Surgery</POSITION><EMAIL_1>30598msm@comb.es</EMAIL_1><ADDRESS><DEPARTMENT>Cirugia Torácica</DEPARTMENT><ORGANISATION>Hospital Universitario Mutua de Terrassa</ORGANISATION><ADDRESS_1>Plaza Dr. Robert, 5</ADDRESS_1><CITY>Terrassa (Barcelona)</CITY><ZIP>08221</ZIP><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34 937365050</PHONE_1><FAX_1>+34 937365059</FAX_1></ADDRESS></PERSON><PERSON ID="4342282B82E26AA20164DA25987DE157" ROLE="AUTHOR"><FIRST_NAME>Manuela</FIRST_NAME><LAST_NAME>Iglesias Sentis</LAST_NAME><POSITION>Adjunto</POSITION><EMAIL_1>toracica@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Cirugia Torácica</DEPARTMENT><ORGANISATION>Hospital Universitario Mutua de Terrassa</ORGANISATION><ADDRESS_1>Plaça Dr. Robert, 5</ADDRESS_1><CITY>Terrassa (Barcelona)</CITY><ZIP>08221</ZIP><COUNTRY CODE="ES">Spain</COUNTRY></ADDRESS></PERSON><PERSON ID="14521" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ramon</FIRST_NAME><LAST_NAME>Rami</LAST_NAME><EMAIL_1>rramip@terra.es</EMAIL_1><URL>http://personal.menta.net/hmt_sct</URL><ADDRESS><DEPARTMENT>Cirugia Torácica</DEPARTMENT><ORGANISATION>Hospital Universitario Mutua de Terrassa</ORGANISATION><ADDRESS_1>Pl. Dr. Robert, 5</ADDRESS_1><CITY>Terrassa (Barcelona)</CITY><ZIP>08221</ZIP><COUNTRY CODE="ES">Spain</COUNTRY><PHONE_1>+34 93 7365050</PHONE_1><FAX_1>+34 93 7365059</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-01-14 09:00:57 +0100" MODIFIED_BY="Sera Tort">
<UP_TO_DATE>
<DATE DAY="15" MONTH="3" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="9" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="20" MONTH="10" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2010-01-14 08:57:03 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-01-14 08:56:45 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="1" YEAR="2010"/>
<DESCRIPTION>
<P>Several edits were done, mainly in risk of bias tables</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-01-14 08:57:03 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2010-01-14 08:56:58 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="9" YEAR="2009"/>
<DESCRIPTION>
<P>Contact author changed</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-01-14 08:57:03 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>This is an update of the 2005 review. Searches were run and four new published papers were identified but conclusions did not change.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-03-10 12:37:01 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-03-10 12:36:30 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-03-10 12:36:30 +0100" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2009-03-10 12:37:01 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-03-10 12:37:01 +0100" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-12-04 09:42:21 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">The use of sealants after lung cancer resection reduce postoperative air leaks and, in many cases, the length of hospitalization</TITLE>
<SUMMARY_BODY MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Air leak (air coming out of the remaining lung tissue) after lung removal for lung cancer is a common postoperative complication that prolongs hospital stay. Surgical sealants (glue), synthetic or made from blood products, have been developed to prevent or to reduce the incidence of air leaks. They are applied during the operation over the lung surfaces that show air leaks. This review of randomized trials found that the use of surgical sealants seems to reduce postoperative air leaks and length of hospitalization. Nevertheless, more and larger randomized trials are needed to clearly determine the effects of surgical sealants, especially on length of hospitalization.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-10-29 13:52:54 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative air leak is a frequent complication after pulmonary resection for lung cancer. It may cause serious complications, such as empyema, or prolong the need for chest tube and hospitalization. Different types of surgical sealants have been developed to prevent or to reduce postoperative air leaks. A systematic review was therefore undertaken to evaluate the evidence on their effectiveness.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>To evaluate the effectiveness of surgical sealants in preventing or reducing postoperative air leaks after pulmonary resection for lung cancer.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-10-29 13:52:54 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the electronic databases MEDLINE (1966 to September 2008), EMBASE (1974 to September 2008), and the Cochrane Central Register of Controlled Trials (CENTRAL)(<I>The Cochrane Library</I>, Issue 3, 2008) and listed references. We hand searched conference proceedings to identify published and unpublished trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomized controlled clinical trials in which standard closure techniques plus a sealant were compared with the same intervention with no use of any sealant in patients undergoing elective pulmonary resection provided that a large proportion of the patients studied had undergone pulmonary resection for lung cancer.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Four reviewers independently selected the trials to be included in the review, assessed methodological quality of each trial and extracted data using a standardized form. Because of several limitations, narrative synthesis was used at this stage.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Sixteen trials, with 1642 randomized patients in total were included. In thirteen trials there were differences between treatment and control patients in reducing postoperative air leaks. This reduction proved to be significant in six trials. Three trials showed a significant reduction in time to chest drain removal in the treatment group. In two trials, the percentage of patients with persistent air leak was significantly smaller in the treatment group. Finally, three trials including 352 patients showed a statistically significant reduction in length of hospital stay.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical sealants reduce postoperative air leaks and time to chest drain removal but this reduction is not always associated with a reduction in length of postoperative hospital stay. Therefore, systematic use of surgical sealants with the objective of reducing hospital stay cannot be recommended at the moment. More and larger randomized controlled clinical trials are needed. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-12-04 09:42:21 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Worldwide, carcinoma of the lung is the main cause of cancer deaths. Over a million new cases are diagnosed annually (<LINK REF="REF-World-Cancer-Report-2003" TYPE="REFERENCE">World Cancer Report 2003</LINK>), about 80% of which are of non-small cell histological types (<LINK REF="REF-Rankin-1986" TYPE="REFERENCE">Rankin 1986</LINK>; <LINK REF="REF-Travis-2004" TYPE="REFERENCE">Travis 2004</LINK>). About 20% of patients with lung cancer undergo surgical resection. Most of them are tumours of non-small cell type. One of the most common complications of lung resection is persistent air leak that happens in more than 5% of patients (<LINK REF="REF-Rice-1992" TYPE="REFERENCE">Rice 1992</LINK>). Persistent air leaks and inadequate control of postoperative pain are identified as the most common causes of delays in discharge from hospital after thoracic operations (<LINK REF="REF-Wright-1997" TYPE="REFERENCE">Wright 1997</LINK>). The air leak may come from the lung parenchyma as a result of surgical manoeuvres or mechanical stapling. In areas of emphysema, an air leak may appear at the site where the staple penetrates the lung tissue. These parenchymal air leaks are usually minor complications and resolve spontaneously within a few days. However, they may be responsible for long postoperative hospital stays and, occasionally, they may require reoperation (<LINK REF="REF-Duque-1997" TYPE="REFERENCE">Duque 1997</LINK>). The air leak may also come from a bronchial stump, either after segmentectomy, lobectomy, bilobectomy or pneumonectomy. Segmental or lobar fistulas usually resolve with prolonged chest tube drainage, although they may require reoperation. Bronchopleural fistula after pneumonectomy is a life-threatening complication associated with a high mortality rate, is commonly associated with post-pneumonectomy  empyema and requires specific and immediate treatment (<LINK REF="REF-Duque-1997" TYPE="REFERENCE">Duque 1997</LINK>).</P>
<P> It is, therefore, important to prevent this complication, either to avoid a prolonged postoperative stay and to prevent infection of the pleural space caused by the opening of the bronchial stumps, which is commonly associated with spillage of purulent material into the contralateral lung and subsequent pneumonia, worsening this serious complication. A variety of surgical sealants have been used in thoracic surgery to prevent air leaks, to prevent and treat bronchopleural fistulas, to prevent oesophageal fistulas, or to control bleeding in cardiac and vascular surgery (<LINK REF="REF-Bayfield-1996" TYPE="REFERENCE">Bayfield 1996</LINK>; <LINK REF="REF-Kjaergard-1996" TYPE="REFERENCE">Kjaergard 1996</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="REF-Radosevich-1997" TYPE="REFERENCE">Radosevich 1997</LINK>). However, the effectiveness of such sealants has not been fully established in patients with lung cancer undergoing pulmonary resection. </P>
<CONDITION MODIFIED="2009-02-22 20:40:57 +0100" MODIFIED_BY="[Empty name]">
<P>Prevention of postoperative air leak after pulmonary resection for lung cancer by using surgical sealants is one of the key points of the postoperative outcome in thoracic surgery. </P>
</CONDITION>
<INTERVENTION MODIFIED="2009-03-26 14:08:14 +0100" MODIFIED_BY="José Ángel Expósito Losada">
<P>A variety of surgical sealants have been used in thoracic surgery to prevent air leaks, to prevent and treat bronchopleural fistulas, to prevent oesophageal fistulas, or to control bleeding in cardiac and vascular surgery (<LINK REF="REF-Bayfield-1996" TYPE="REFERENCE">Bayfield 1996</LINK>; <LINK REF="REF-Kjaergard-1996" TYPE="REFERENCE">Kjaergard 1996</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="REF-Radosevich-1997" TYPE="REFERENCE">Radosevich 1997</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Sealing air leak after a lung cancer resection by using surgical sealants should avoid a prolonged postoperative stay and prevent infection of the pleural space caused by the opening of the bronchial stumps, which is commonly associated with spillage of purulent material into the contralateral lung and subsequent pneumonia, worsening this serious complication.</P>
</THEORY>
<IMPORTANCE MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>The effectiveness of such sealants in patients with lung cancer undergoing pulmonary resection has not been fully established.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2009-02-22 21:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>To evaluate whether standard closure techniques plus a sealant are more effective than standard tissue closure techniques alone in patients undergoing elective pulmonary resection for lung cancer.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-11-27 10:37:46 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2009-02-23 19:39:59 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled clinical trials in lung cancer patients.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Patients undergoing elective pulmonary resection mainly for lung cancer. We considered patients with pulmonary metastatic cancer, benign lung diseases and lung volume reduction surgery if they represented a small proportion in a lung cancer trial.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Standard closure techniques, such as stapling or suturing, plus a sealant, compared to the same intervention with no use of sealant. We treated bronchial and parenchymal sutures separately.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>We considered the following outcomes:</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2009-02-23 19:42:37 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative hospital stay.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2009-02-23 19:43:24 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative morbidity and mortality, postoperative chest tube time</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-11-27 10:35:10 +0100" MODIFIED_BY="[Empty name]">
<P>We searched MEDLINE (through PubMed) from 1966 to September 2008, EMBASE (through OVID) from 1974 to September 2008, and the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I>, Issue 3, 2008), and we also searched listed references and handsearched conference proceedings to identify published and unpublished trials. We adapted a search strategy for all databases (see Appendix 1).</P>
<P>The authors have participated in the main conferences since the last review of this topic and identified no further relevant studies on the topic (16<SUP>th  </SUP>European Conference on General Thoracic Surgery, European Society of Thoracic Surgeons. Bolonia, Italy. 8-11 June  2008). </P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-11-27 10:37:46 +0100" MODIFIED_BY="[Empty name]">
<P>Four independent reviewers evaluated the abstracts obtained from the electronic and manual searches. We obtained a hard copy of the identified studies to determine whether they met the inclusion criteria. Any disagreement was resolved by consensus. Bibliographic references were handled with the ProCite software.We entered complete information related to methods, characteristics of participants, characteristics of the intervention, the different groups of comparison, as well as the results, follow-up time, and funding entity of every study in a spreadsheet specifically designed for this purpose.</P>
<P>We attempted only a narrative synthesis at this stage due to the heterogeneity of studies regarding type of intervention (type of sealant), outcome measures and analysis.</P>
<QUALITY_ASSESSMENT MODIFIED="2009-11-27 10:37:46 +0100" MODIFIED_BY="[Empty name]">
<P>In order to estimate the validity of the included studies, the risk of bias in the results of each eligible study was assessed according to the criteria mentioned in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). Criteria for judging risk of bias were sequence generation (a description for allocating interventions to participants based on a random process), allocation sequence concealment (a description of any method to secure implementation of the random assignments to prevent that allocations could have been foreseen), blinding of participants, personnel and outcome assessors (a description of measures used to blind study participants and personnel for knowledge of which intervention a participant received), and incomplete outcome data (a description of the level of completeness of each outcome, including attrition and exclusions). </P>
</QUALITY_ASSESSMENT>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-12-04 09:42:21 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2009-12-04 09:39:45 +0100" MODIFIED_BY="[Empty name]">
<P>Our preliminary literature searches identified 34 potentially eligible studies (one unpublished) which investigated the role of surgical sealants for preventing air leaks after pulmonary resections in patients with lung cancer. We excluded non-randomized clinical trials and case-control studies. </P>
<P>We eventually included four new randomized controlled clinical trials in the update of this review (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>). Twelve trials were included from the previous version of the review (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>).</P>
<P>A total of 1870 patients were included in the sixteen trials. Of the 1870 patients, 218 were not eligible and 10 were pilot patients who were randomized but not included in the final statistical analysis. Overall, 1642 patients were randomized to receive either standard closure techniques or the same standard closure techniques plus a surgical sealant and were included in the final statistical analysis. The patients in all the studies were in their late fifties or early sixties and most of them were male.</P>
<P>Only five trials (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK> ) were conducted exclusively in patients with lung cancer. In the others trials the proportion of lung cancer patients was high: 20 out of 28 (71.4%) (<LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>); 36 out of 50 (72%) (<LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>); 40 out of 50 (80%) (<LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>); 97 out of 114 (85%) (<LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>); 53 out of 66 (80.3%) (<LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>); 16 out of 24 (66.6%) (<LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>); 108 out of 124 (87%) (<LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>); 77 out of 100 (77%) (<LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>); and 48 out 52 (92%) (<LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>). In <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>, 156 out of 172 (90%) were patients with lung cancer or metastasis. In <LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>, these data were not available.</P>
<P>Fibrin glue, a sealant that consists of a sealer solution (fibrinogen, factor XIII, fibronectin, aprotinin and plasminogen) and a thrombin solution (thrombin and calcium chloride) was used in six trials (<LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK> ). A synthetic sealant consisting of polyethylenglycol, trimethylene carbonate and acrylate was used in two trials (<LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>). A water soluble polyethylene glycol-based gel photopolymerizable was used in one trial (<LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>). A polymeric biodegradable sealant (polyethylenglycol-based cross-linker, functionalized with succinate groups ([PEG-(SS)2]) with human serum albumin-USP) was used in two trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>). TachoComb, an absorbable patch consisting of an equine-collagen fleece coated with human fibrinogen and human thrombin, was used in one study (<LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>). TachoSil, a further development of the TachoComb that does not contain any other component than human fibrinogen and human thrombin, was used in three studies ( <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>). Vivostat, an autologous fibrin sealant, was used in the remaining trial (<LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>).</P>
<P>In six trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK> ) patients were randomized after checking intraoperative air leaks. In the other ten trials the staple lines and cut surfaces of the lung parenchyma were routinely covered with the sealant regardless of the presence of air leaks. The sixteen trials differed in the way the sealant was applied: aerosolized spraying mechanism, double syringe (with or without photopolimerization by a xenon light) and direct application of an absorbable patch.</P>
<P>The presence of air leaks was evaluated (in some studies also scored according to Macchiarini&#8217;s method) intraoperatively by immersing the lung tissue in saline serum and ventilating the lung. If there are leaks, air bubbles are seen coming out from the lung. Postoperatively, the air leaks are seen and measured, either in the underwater drainage chamber which is connected to one or two chest tubes (air bubbles are seen in the water seal and, in some studies scored according to Cerfolio`s classification of 1998), or using a digital mass airflow sensor device connected to the chest drain-suction unit.</P>
<P>Seven trials reported data on persistent air leak (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK> ). Persistent air leak was defined in all of them as the presence of air leak on the seventh postoperative day or beyond. The other nine studies did not define persistent air leaks or did not study this issue specifically.</P>
<P>The characteristics of the 16 included studies are shown in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>More information about included studies can be found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>
<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>. USA. Multicenter prospective randomized control study. Ninety-five patients requiring pulmonary resections other than pneumonectomy and decortication were assigned to the sealant group (standard surgical treatment plus polymeric biodegradable sealant) and fifty-three patients to the control group (standard procedures to control air leaks with no addition of sealant). Primary outcome was proportion of patients who remained air leak free following surgery. Secondary outcome was the proportion of intraoperative air leaks in each group that were sealed or reduced, proportion of patients in each group that was free of air leaks immediately following surgery, duration of postoperative air leak, chest tube duration and length of hospitalization. Randomized patients included only those who had at least one significant air leak (&#8805; 2.0 mm in size) after pulmonary resection.</P>
<P> <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>. Sweden. Prospective blinded randomized study. Forty patients undergoing a standard pulmonary lobectomy were randomized; 20 patients were assigned to the autologous fibrin sealant group and 20 patients were assigned to the control group (standard lobectomy with no additional interventions). Outcomes were: rate of air leak on the day of the operation and daily thereafter until chest drains were removed, time to chest tube removal, 24-h and chest-tube drainage (bleeding/exudation) volume at removal of chest tube, duration of thoracic epidural analgesia treatment and length of postoperative hospital stay. All patients had lung tumours limited to one lobe.</P>
<P> <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>. USA. Prospective randomized blinded study.  One hundred patients undergoing planned open anatomic resection or wedge resection were randomized intraoperatively. Fifty patients were assigned to the treatment group (patients treated with an application of fibrin glue at the end of the procedure) and 50 to the control group (received no additional treatments). Outcomes were incidence and duration of air leaks, prolonged alveolar air leaks, the volume of pleural drainage, the time to tube removal and the postoperative length of stay and any complications related to treatment.</P>
<P>
<LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>. Canada. Randomized controlled clinical trial. Twenty-eight patients undergoing lobectomy. Fourteen were included in the fibrin group (after division of lung fissures with stapling devices, two millilitres of fibrin glue were applied to staple lines and any cut surfaces of the lung regardless of the presence or absence of air leaks), and 14 were controls (division of lung fissures with stapling devices, without additional fibrin glue). Outcomes were the duration of postoperative air leaks, chest tube drainage and postoperative hospitalization.</P>
<P>
<LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>. Hungary. Multicenter randomized and prospective study. One hundred and eighty-nine patients undergoing standard lobectomy or bilobectomy for lung cancer were randomized. Ninety-six patients were assigned to the treatment group (standard surgical resection plus absorbable patch consisting of an equine-collagen fleece coated with human fibrinogen and human thrombin), and 93 to the control group (surgical standard procedures with no additional treatments). Primary outcome  was incidence of air leakage 48 hours after lobectomy. Secondary outcomes were reduction of intraoperative air leakage intensity after the first test treatment, intensity and duration of postoperative air leakage up to postoperative day 9, postoperative mortality and morbidity.</P>
<P>
<LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>. France.  Randomized controlled trial. Twenty-four patients requiring pulmonary resection other than pneumonectomy were randomized, 13 were assigned to the treatment group (a synthetic sealant that was applied to all identified surgical sites: staple lines, suture lines, areas of dissection or adhesiolysis) and 11 were controls (no addition of sealant after resection). Primary outcomes were persistence of air leaks during operation and duration of chest tube air leaks. Secondary outcomes were time from operation to chest tube removal and hospital discharge, hospitalization time and costs.</P>
<P>
<LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>. Denmark. Randomized controlled clinical trial. One hundred and fourteen patients undergoing pulmonary resections including pneumonectomy. Fifty-five were assigned to the sealant group (standard surgical treatment plus fibrin glue applied to bronchial stumps and lung surfaces) and 59 to the control group (standard surgical treatment with no additional fibrin glue). Primary outcomes were difference in air-tolerance-pressure before and after fibrin gluing, rate of patients with postoperative bronchopleural or pulmonary leakages and number of days with persistent air leakage. Secondary outcomes were length of stay in the intensive care unit, length of hospital stay, duration of intubation after surgery, number of days with chest tubes, rate of complications, daily amount of secretion from chest tubes, and general condition of the patient.</P>
<P>
<LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>. France. Randomized controlled clinical trial. One hundred and twenty patients requiring pulmonary lobectomy or bilobectomy were randomized. Fifty-nine patients were assigned to the treatment group (a synthetic sealant was applied to all identified surgical sites leaking air or at risk of leaking air), and 61 patients were controls (after standard surgical treatment patients underwent no further procedures). Primary outcome was safety of surgical lung sealant by surveillance for unexpected adverse events during follow-up. Secondary outcomes were the percentage of alveolar air leaks effectively sealed at operation after sealant application, durability of alveolar air leaks sealing and potential effect of sealant on the in-hospital stay.</P>
<P>
<LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>. USA. Randomized controlled clinical study. One hundred and seventy two patients undergoing lobectomy, wedge and segmental resections. One hundred and seventeen were assigned to the treatment group (standard surgical treatment plus a synthetic sealant was applied to all sites of surgical manipulation), and 55 patients were assigned to the control group (standard surgical treatment with no additional fibrin glue). Primary outcome was the percentage of patients free of air leakage throughout hospitalization. Secondary outcomes were control of air leaks intraoperatively, time to postoperative air leak cessation, time to chest tube removal, time to hospital discharge and safety outcomes.</P>
<P>
<LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>. United Kingdom. Randomized controlled clinical trial. Sixty-six patients undergoing lobectomy segmentectomy or decortication were randomized. Thirty-three were assigned to the fibrin glue group (fibrin glue was applied to leaking areas), and 33 patients were assigned to the control group (standard surgical procedures to control air leaks were applied with no additional fibrin glue). Outcomes were days of postoperative air leaks, days of intercostal drainage, and length of in-hospital stay.</P>
<P>
<LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>. France. A prospective randomized study. Fifty patients undergoing a pulmonary resection except pneumonectomy were randomized. Twenty five patients were treated with fibrin glue at the end of the procedure (intervention group) and 25 patients received no additional interventions (control group). Outcomes were quality of aerostasis, post-operative drainage, persistence of residual collection or faulty re-expansion after removal of drains, the need for repeated drainage and length of post-operative hospital stay.</P>
<P>
<LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>. France. Prospective randomized study. Fifty patients undergoing a pulmonary resection except pneumonectomy were randomized, 25 patients (intervention group) were treated with fibrin glue at the end of the procedure and 25 patients (control group) received no additional interventions. Outcomes were post-operative amount of drainage, persistence of residual collection or faulty re-expansion after removal of drains and length of post-operative hospital stay.</P>
<P>
<LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>. Austria, Italy, Denmark, Germany, Hungary. Open, randomized, prospective, multicenter, parallel-group trial. Three hundred and one patients requiring pulmonary lobectomy were randomized. One hundred and forty-nine were assigned to the treatment group (standard surgical resection plus absorbable patch consisting of human fibrinogen and human thrombin), and 150 patients were assigned to the standard treatment group (surgical standard procedures with no additional treatments). Primary outcome was duration of postoperative air leak. Secondary outcomes were reduction of intraoperative air leakage intensity after treatment, number of days after removal of last chest tubes, adverse effects.</P>
<P>
<LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>. Italy. Randomized, prospective, controlled parallel-group trial. Forty patients were randomized. Twenty patients were assigned to the treatment group (electrocautery surgical dissection of interlobar fissures plus a collagen patch with human fibrinogen and human thrombin) and 20 were assigned to the standard treatment group (routine surgical procedure with staplers with no additional treatments). Primary outcomes were the percentage of demonstrated intraoperative alveolar air leak effectively sealed after application of the sealant and to compare the proportion of patients in the sealant and control groups who were free of air leaks throughout hospitalization. Secondary outcomes were postoperative air leaks, the moment of chest tube removal, length of hospitalization, costs of the procedure and hospitalization, safety of the sealant treatment by surveillance of the incidence and severity of complications.</P>
<P>
<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>. Austria. Randomized, prospective, open-label, parallel group study carried out at a single center. One hundred and fifty-two patients were randomized. Seventy-seven were assigned to the treatment group (parenchymal suturing, stapling or electrocautery plus a collagen patch with human fibrinogen and human thrombin), and 75 were assigned to standard treatment group (standard surgical procedure with parenchymal suturing, staplers, and electrocautery with no additional treatments). Primary outcome was quantitative measure of postoperative air leaks at days one and two. Secondary outcomes were mean time to chest drain removal, mean time to hospital discharge.</P>
<P> <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>. United Kingdom. Prospective, randomized, single-blind, controlled study. Fifty-two patients were randomized. Twenty-five were assigned to the treatment arm (parenchymal suturing or stapling plus a mixture of bovine serum albumin and glutaraldehyde), and 27 were assigned to the non-interventional arm (standard surgical procedure with no additional treatments). Primary outcomes were duration of air leak, duration of intercostal drainage, and duration of hospital stay. Secondary outcomes were postoperative complications other than air leaks.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Eighteen studies were excluded (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). The reasons for exclusion were comparative but non-randomized studies and randomized controlled trials in animals.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-12-04 09:42:21 +0100" MODIFIED_BY="[Empty name]">
<P>Twelve trials (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>) had an adequate type of randomization (sequence generation), three trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>) had an unclear type of randomization and one trial (<LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>) had no data about type of randomization. Regarding the risk of bias related to an adequate or inadequate allocation sequence concealment, nine trials (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>) presented a proper allocation concealment, whereas the allocation concealment was unclear in six trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>) and was not adequate in one trial (<LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>).</P>
<P>In two studies (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>) air leaks were assessed by qualified hospital staff, including investigators. Blinding of outcome assessment was not specified in the other fourteen studies. One study (<LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>) clearly specified that it was a pilot study and no attempts were made to calculate a sample size to provide statistical power sufficient for confident evaluation of the results.</P>
<P>There were no withdrawals in six trials (<LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK> ). Withdrawal in the remaining ten trials was clearly specified.</P>
<P>In all trials but two (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>) the period of patient recruitment and whether patients were consecutive or not were clearly described.</P>
<P>Follow-up was limited to the postoperative period in ten trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK> ). In five studies (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>) the follow-up was extended beyond the perioperative period (6 to 18 months). Patients discharged with valves were followed up until chest tube removal in two trials (<LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>The outcomes measured in the different trials differed slightly, but most of the authors emphasized the duration of postoperative air leaks, day of chest tube removal and length of postoperative stay.</P>
<P>Primary outcomes</P>
<OL>
<LI>Length of hospital stay. In three trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>) the length of hospital stay was significantly reduced in the treatment group: treated patients were discharged on the sixth postoperative day and patients in the control group patients on the seventh in both the Allen&#8217;s and Tansley&#8217;s trials; and at 6.2 days (treatment group) and 7.7 days (control group)<SUP> </SUP>postoperatively in <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>. In two studies these data were not available (<LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>). The other eleven studies did not find statistically significant difference.</LI>
</OL>
<P>Secondary outcomes</P>
<OL>
<LI>Morbidity.</LI>
<UL>
<LI>Empyema: In four trials some patients developed empyema. (<LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>). In one of them (<LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK>), 3% of patients in the control group developed empyema and 0% in the treatment group. In the other three trials only patients in the treatment group developed empyema. The percentage of empyema was 3.8%, 6.78% and 3% in <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>, <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK> and <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>respectively. These differences were not statistically significant. Mean air leaks duration: Six trials found statistically significant differences between treatment patients and control (<LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK> ;).</LI>
</UL>
<LI>Mortality. No mortality related to the use of sealants was described.</LI>
<LI>Chest tube removal. Three trials found statistically significant differences between treatment patients and controls (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK> ). The mean duration to chest tube removal in days in the treatment group and in the control group was 3.5 and 5, respectively, in the Fabian&#8217;s trial; 4 and 5, respectively, in the Tansley&#8217;s trial, and 5.1 and 6.3, respectively in the Anneg&#8217;s trial. In four trials these data were not available (<LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>). The other nine studies did not find any statistically significant differences. </LI>
<LI>Mean duration of air leaks. Mean duration of air leaks in hours in Porte's trial was 33.7 in the treatment group and 63.22 in the control group and 30.9 and 52.3 respectively in Wain's trial. Mean duration of postoperative air leaks in days was 1.1 in the treatment group and 3.1 in the control group in the Fabian&#8217;s trial; 1 and 4 respectively in the Tansley&#8217;s trial; and 1.7 and 3.7 respectively in the Droghetti&#8217;s trial. In the Marta&#8217;s trial, following surgery, treatment patients had a lower incidence of alveolar air leaks at all cut-off time points. Six trials did not find any statistically significant differences between treatment patients and control (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Fleisher-1990" TYPE="STUDY">Fleisher 1990</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Wong-1997" TYPE="STUDY">Wong 1997</LINK> ). In four trials these data were not available ( <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Wurtz-1990" TYPE="STUDY">Wurtz 1990</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>).</LI>
<LI>Persistent air leaks. Only in seven trials were these data available. The difference between treatment patients and control group was clearly reported as statistically significant in two of them (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>). In the Fabian&#8217;s trial, the percentages of patients with persistent air leaks were 2% in the treatment group and 16% in the control group. In the Anegg&#8217;s trial, the percentages were 24% and 32.46% respectively. One study (<LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>) found a difference in the percentage of patients with persistent air leaks but the authors did not report if the differences were significant: 2 (8%) patients in the treatment arm and 3 (11%) patients in the control arm had persistent air leak.</LI>
<LI>Postoperative air leaks. In twelve trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK> ) a significantly higher percentage of treated patients than control patients reduced or remained free of air leaks during hospitalization, leading to a shorter median duration of air leaks and/or intercostal chest drain. </LI>
<UL>
<LI>Wurtz: 58% of postoperative air leaks in treated patients vs. 72% in controls.</LI>
<LI>Mouritzen: 39% of postoperative air leaks in treated patients vs. 66% in controls.</LI>
<LI>Macchiarini: 77% of patients remaining free from air leaks in the treated group vs. 9% in the control group.</LI>
<LI>Porte: Mean percentage of patients free of air leaks at day 4 was 87% in the treatment group vs. 58.5% in the control group.</LI>
<LI>Wain: 39% of treated patients remained free of air leaks during hospitalization vs. 11% in the control group.</LI>
<LI>Fabian: Overall incidence of air leaks in the treatment group 34% vs. 68% in the control group.</LI>
<LI>Lang: Air leak intensity was reduced in 74% in the treatment group vs. 51% in the control group.</LI>
<LI>Allen: The sealant group had significantly fewer patients with postoperative air leaks: 65% compared with the control group: 86%</LI>
<LI>Belboul: Significantly fewer patients had air leak at any time in the treatment group:40% vs. 80%</LI>
<LI>Tansley: Patients in the sealant arm had significantly shorter median duration of air leaks and intercostal chest drain (P &lt; 0.001 and P = 0.012 respectively)</LI>
<LI>Marta: Significantly fewer patients had lower incidence of alveolar air leaks at all time points in the treatment group leading to a statistically significant reduction in post-operative air leakage duration compared to standard surgical treatment (P = 0.030).</LI>
<LI>Droghetti: statistically significant reduction of the overall incidence of air leakages were found in the sealant group: 50% vs. 95%.</LI>
</UL>
</OL>
<P>This reduction in postoperative air leaks did not translate into any significant differences in the duration of hospital stay except in three trials. In Allen's trial, mean hospital stay was 6 days in the treatment group and 7 days in the control group; in Anegg&#8217;s trial, 6.2 and 7.7 days respectively; and in Tansley&#8217;s trial, 6 and 7 days respectively. Nor was there any difference in postoperative chest tube time except in three trials. In Fabian's trial, mean postoperative chest tube time was 3.5 days in the treatment group and 5 days in the control group; in Anegg&#8217;s trial, 5.1 and 6.3 days respectively; and in Tansley&#8217;s trial, 4 and 5 days, respectively. At the interim analysis of one trial (<LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>), the difference in favour of the sealant arm in terms of shorter median duration of air leaks, intercostal chest drain and hospital stay, lead to stopping the trial earlier than planned.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative air leaks originating at the bronchial stumps or parenchymal surfaces after pneumonectomy or lesser pulmonary resections for lung cancer are a cause of prolonged hospital stay and may be the origin of empyema and other serious, life-threatening complications, especially when they occur after pneumonectomy. After pulmonary resection more than 70% of patients have intraoperative air leaks. Persistent air leaks (more than 7 days) occur in 15% to 25% of patients. Prolonged air leak is often the only morbidity associated with lung resection and the only reason for prolonged length of hospital stay. Clinical trials specifically designed to study the effectiveness of surgical sealants to prevent postoperative air leaks in lung cancer patient are scarce. Only five of them (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>) were conducted exclusively in patients with lung cancer. In the other trials the proportion of lung cancer patients included in each trial was high.</P>
<P>A variety of sealants, synthetic (<LINK REF="REF-Eng-1989" TYPE="REFERENCE">Eng 1989</LINK>; <LINK REF="REF-Nomori-1999" TYPE="REFERENCE">Nomori 1999</LINK>; <LINK REF="REF-Nomori-2000" TYPE="REFERENCE">Nomori 2000</LINK>; <LINK REF="REF-Otani-1999" TYPE="REFERENCE">Otani 1999</LINK>; <LINK REF="REF-Sabanathan-1993" TYPE="REFERENCE">Sabanathan 1993</LINK>), composed of pooled plasma (<LINK REF="REF-Grunenwald-1989" TYPE="REFERENCE">Grunenwald 1989</LINK>) or single-donor plasma products (<LINK REF="REF-Matar-1990" TYPE="REFERENCE">Matar 1990</LINK>; <LINK REF="REF-Matthew-1990" TYPE="REFERENCE">Matthew 1990</LINK>), or composed of fibrin plus synthetic products (<LINK REF="REF-Miyamoto-2003" TYPE="REFERENCE">Miyamoto 2003</LINK>; <LINK REF="REF-Passage-2005" TYPE="REFERENCE">Passage 2005</LINK>; <LINK REF="REF-Potaris-2003" TYPE="REFERENCE">Potaris 2003</LINK>) has been used with an apparent beneficial effect, although not in clinical trial settings. The therapeutic use of fibrin sealant is not limited to thoracic surgery; most surgical specialities have used it in one way or another, both in open surgery and in endoscopic procedures (<LINK REF="REF-Dunn-1999" TYPE="REFERENCE">Dunn 1999</LINK>). In thoracic surgery, in addition to its intraoperative use to prevent or to reduce postoperative air leaks, sealants have also been used to treat postoperative bronchopleural fistulas (<LINK REF="REF-Hollaus-1998" TYPE="REFERENCE">Hollaus 1998</LINK>). Fibrin glue has been used alone or combined with polyglycolide non-woven felt to reinforce the target area (<LINK REF="REF-Mizuno-1995" TYPE="REFERENCE">Mizuno 1995</LINK>).</P>
<P>Fibrin glue has been the adhesive material most widely used in thoracic surgery during last 10 years. The interest in this product decreased since the randomized trials conducted by Fleisher and Wong demonstrated that there was no difference between the treatment and control groups in the number of postoperative air leaks, duration of chest drain and in hospitalization due to insufficient fibrin glue adhesion.</P>
<P>In Porte' s trial, Advaseal, a synthetic lung sealant, reduced perioperative and postoperative alveolar air leaks in patients who had moderate or severe air leaks after all conventional measures to reduce air leaks had been used. In this trial, the mean duration of hospital stay was not different in the control and treatment groups, mainly because of the higher percentage of empyema in the treated group. Empyema could be produced because this sealant did not maintain its adhesive properties over time and acted as a foreign body in the pleural space. Porte only used synthetic sealant in patients with major perioperative air leaks.</P>
<P>On Wain's trial, the benefit of sealant application was seen in both the high- and low-risk air leak subgroups of patients, implying that selection of patients for sealant application based on the risk for air leak alone may not be justified. Lang demonstrated that there is no evidence that a prophylactic use of an additional sealant after having achieved air tightness with standard surgery is of any value since the incidence of secondary air leaks, at least in a standard population undergoing lobectomy, is low.</P>
<P>Allen's trial is the only study with a shorter hospitalization for patients who had sealant applied, BioGlue, compared with controls. Nevertheless there is not any difference in chest tube duration. This could be due to several reasons: First, patients with air leaks may be kept in the hospital for observation one more day after the chest tube is removed, whereas if the chest tube is kept in just for high volume drainage, patients may be sent home immediately after removal of the chest tube. Second, more Heimlich valves were used in sealant patients (10%) than controls (2%). And third, the measurement may not be sensitive enough because the authors measured chest tube duration by days and not by hours.</P>
<P>In Fabian's trial fibrin glue was applied using a device that provides a fine aerosolized mist spray under pressure. This method allows precise coverage of large surfaces using small amounts of glue components. Reduced incidence of air leaks and persistent air leaks as well as earlier time to drain removal in treated patients, in contrast to other studies, may be related to the amount of product applied and to the method of application (pressurized mist system is superior to the two-syringe technique).</P>
<P>Since the last version of this review, four trials have been included (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK> ). Three of them used TachoSil (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>) and one of them used BioGlue (<LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>). These recent trials do not support the increased risk of infectious complications in the treated group reported in previous studies. In fact there were no postoperative infectious complications associated to the application of the sealant.</P>
<P>Three recent trials (<LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>) have found differences in duration of hospitalization. Two of these trials found statistically significant differences in mean hospitalization length in favour of the treatment arm. The difference in mean hospitalization days did not achieve statistical significance in Droghetti&#8217;s trial (<LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>); however, it was shorter in the treatment group than in the control group (11.0 days versus 14.3 days). These recent data support the results of the only previous randomized trial (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>), in which the duration of hospitalization was significantly shorter in the treatment group. Nevertheless, eleven trials did not find statistically significant differences in hospitalization length.</P>
<P>The fact that different sealants have been used and different outcomes have been evaluated makes any in-depth analysis of the data difficult.</P>
<SUMMARY_OF_RESULTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>In summary, in twelve trials (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Belboul-2004" TYPE="STUDY">Belboul 2004</LINK>; <LINK REF="STD-Droghetti-2008" TYPE="STUDY">Droghetti 2008</LINK>; <LINK REF="STD-Fabian-2003" TYPE="STUDY">Fabian 2003</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>; <LINK REF="STD-Macchiarini-1999" TYPE="STUDY">Macchiarini 1999</LINK>; <LINK REF="STD-Marta-2008" TYPE="STUDY">Marta 2008</LINK>; <LINK REF="STD-Mouritzen-1993" TYPE="STUDY">Mouritzen 1993</LINK>; <LINK REF="STD-Porte-2001" TYPE="STUDY">Porte 2001</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>; <LINK REF="STD-Wain-2001" TYPE="STUDY">Wain 2001</LINK>; <LINK REF="STD-Wurtz-1992" TYPE="STUDY">Wurtz 1992</LINK>) there was a statistically significant difference in the reduction of air leaks in the treated subjects compared with controls. However, this benefit only had an effect on significant reduction of the length of hospital stay in three of them (<LINK REF="STD-Allen-2004" TYPE="STUDY">Allen 2004</LINK>; <LINK REF="STD-Anegg-2007" TYPE="STUDY">Anegg 2007</LINK>; <LINK REF="STD-Tansley-2006" TYPE="STUDY">Tansley 2006</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>The relatively low number of patients in each trial and the various surgical sealants used mean that this evidence should be applied with caution.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2009-08-17 18:32:00 +0200" MODIFIED_BY="[Empty name]">
<P>Sixteen trials, with 1642 randomized patients in total were analysed. The risk of bias was assessed for each study. The allocation sequence was adequately generated in 12 trials. Allocation was adequately concealed only in 5 trials and was unclear in 10. The knowledge of the allocated interventions was adequately prevented during the study in 2 trials and it was unclear in 11 trials. Incomplete outcome data were adequately addressed in all trials. </P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2009-03-01 08:02:44 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical sealants have some beneficial effect in reducing postoperative air leaks, but systematic use of surgical sealants in clinical practice cannot be recommended at the moment.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Since the last revision, most new trials have a small number of patients that prevent solidly based conclusions. More and larger randomized controlled clinical trials with homogeneous criteria on type of sealant, method of sealant delivery, and patient selection are needed in order to produce reliable evidence on the usefulness of sealants.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-10-20 11:28:48 +0200" MODIFIED_BY="[Empty name]">
<P>We would like to thank José Ángel Expósito Losada, Ivan Solà and Sera Tort, members of the Lung Cancer Collaborative Review Group, Hospital de la Santa Creu i Sant Pau, Barcelona Spain, for their encouragement, editorial assistance and constant help along all steps of this review; Mr. Peter Goldstraw, from the Royal Brompton Hospital, London and Imperial College, United Kingdom, for providing useful additional information on the trial of which he was senior researcher; Dr Haruhiko Kondo, from the Shizuoka Cancer Center, Tokyo, Japan, for his kindness and promptness in faxing a copy of a Japanese paper; Dr. Prof. Alain Wurst from Centre Hospitalier Régional Universitaire de Lille, Lille, France for providing us with two of his published papers; Dr. Miquel Mateu, from the Thoracic Surgery Service, Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain, co-author of the first review on this subject, who passed away in 2003; and Mrs. Conxi Caro, from the Library of Hospital Universitari Mutua de Terrassa, for her enthusiasm and diligence in searching for difficult references.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-03-01 08:04:55 +0100" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Conceiving the review: Jose Belda-Sanchis (JBS), Mireia Serra-Mitjans (MSM), Manuela Iglesias-Sentis (MIS), Ramon Rami-Porta (RRP)</P>
<P>Co-ordinating the review: JBS</P>
<P>Undertaking manual searches: JBS, MSM, MIS</P>
<P>Screening search results: JBS, MSM, MIS, RRP</P>
<P>Organizing retrieval of papers: JBS</P>
<P>Screening retrieved papers against inclusion criteria: JBS, MSM, MIS, RRP</P>
<P>Appraising quality of papers: JBS, MSM, MIS, RRP</P>
<P>Abstracting data from papers: JBS, MSM, MIS</P>
<P>Writing to authors of papers for additional information: None</P>
<P>Providing additional data about papers: None</P>
<P>Obtaining and screening data on unpublished studies: None</P>
<P>Data management for the review: JBS</P>
<P>Entering data into Review Manager (RevMan 5): JBS</P>
<P>RevMan statistical data: None</P>
<P>Other statistical analysis not using RevMan: None</P>
<P>Double entry of data: None</P>
<P>Interpretation of data: JBS, MSM, MIS, RRP</P>
<P>Statistical inferences: JBS</P>
<P>Writing the review: JBS</P>
<P>Guarantor for the review: JBS</P>
<P>Person responsible for reading and checking review before submission: JBS, RRP</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-03-03 16:50:21 +0100" MODIFIED_BY="[Empty name]">
<P>None</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Allen-2004" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Allen 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allen MS, Wood DE, Hawkinson RW, Harpole DH, McKenna RJ, Walsh GL et al and the 3Mtm Surgical Sealant Study Group</AU>
<TI>Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2004</YR>
<VL>77</VL>
<PG>1792-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-03 01:27:33 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anegg-2007" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Anegg 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A and Smolle-Jüttner F</AU>
<TI>Efficiency of fleece-bound sealing (TachoSil®) of air leaks in lung surgery: a prospective randomized trial</TI>
<SO>European Journal of Cardio-thoracic Surgery</SO>
<YR>2007</YR>
<VL>31</VL>
<PG>198-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Belboul-2004" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Belboul 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Belboul A, Dernevik L, Aljassim O, Skrbic B, Radberg G, Roberts D</AU>
<TI>The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy: a prospective randomized, blinded study</TI>
<SO>European Journal of Cardio-thoracic Surgery</SO>
<YR>2004</YR>
<VL>26</VL>
<PG>1187-91</PG>
<IDENTIFIERS MODIFIED="2009-03-03 01:39:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-03 01:36:13 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Droghetti-2008" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Droghetti 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Droghetti A, Schiavini A, Muriana P, Folloni A, Picarone M, Bonadiman C et al</AU>
<TI>A prospective randomized trial comparing completion technique of fissures for lobectomy: Stapler versus precision dissection and sealant</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2008</YR>
<VL>136</VL>
<PG>383-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fabian-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Fabian 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fabian T, Federico JA, Ponn RB</AU>
<TI>Fibrin glue in pulmonary resection: a prospective randomized, blinded study</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2003</YR>
<VL>75</VL>
<PG>1587-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleisher-1990" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Fleisher 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fleisher AG, Evans KG, Nelems B, Finley RJ</AU>
<TI>Effect of routine fibrin glue use on the duration of alveolar air leaks after lobectomy</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1990</YR>
<VL>49</VL>
<PG>133-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lang-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Lang 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lang G, Csekeö A, Stamatis G, Lampl L, Hagman L, Marta GM et al</AU>
<TI>Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy</TI>
<SO>European Journal of Cardio-thoracic Surgery</SO>
<YR>2004</YR>
<VL>25</VL>
<PG>160-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Macchiarini-1999" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Macchiarini 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Macchiarini P, Wain J, Almy S, Dartevelle P</AU>
<TI>Experimental and clinical evaluation of a new synthetic, absorbable sealant to reduce alveolar air leaks in thoracic operations</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1999</YR>
<VL>117</VL>
<PG>751-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marta-2008" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Marta 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marta GM, Facciolo F, Ladegaard L, Dienemann H, Csekeo A, Rea F et al</AU>
<TI>Tachosil vs. standard surgical treatment for air leakage in pulmonary lobectomy</TI>
<SO>Interactive CardioVascular and Thoracic Surgery</SO>
<YR>2008</YR>
<VL>suppl. 2</VL>
<PG>abst 168-P</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mouritzen-1993" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Mouritzen 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mouritzen C, Dromer M, Keinecke H</AU>
<TI>The effect of fibrin gluing to seal bronchial and alveolar leakage after pulmonary resections and decortications</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>75-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porte-2001" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Porte 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porte HL, Jany T, Akkad R, Conti M, Gillet PA, Guidat A et al</AU>
<TI>Randomized controlled trial of a synthetic sealant for preventing alveolar air leaks after lobectomy</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2001</YR>
<VL>71</VL>
<PG>1618-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tansley-2006" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Tansley 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tansley P, Al-Mulhim F, Lim E, Ladas G, and Goldstraw P</AU>
<TI>A prospective, randomized, controlled trial of the effectiveness of BioGlue in treating alveolar air leaks</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2006</YR>
<VL>132</VL>
<PG>105-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wain-2001" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wain 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wain JC, Kaiser LR, Johnstone DW, Yang SC, Wright CD, Friedberg JS et al</AU>
<TI>Trial of a novel synthetic sealant in preventing air leaks after lung resection</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2001</YR>
<VL>71</VL>
<PG>1623-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-1997" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wong 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wong K, Goldstraw P</AU>
<TI>Effect of fibrin glue in the reduction of post-thoracotomy alveolar air leak</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1997</YR>
<VL>64</VL>
<PG>979-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wurtz-1990" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wurtz 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wurtz A, Chambon JP, Sobecki L, Batrouni R, Huart JJ, Burnouf T</AU>
<TI>Use of a fibrin glue in partial pulmonary excision surgery. Results of a controlled trial in 50 patients</TI>
<TO>Utilisation d'une colle biologique en chirurgie d'exérèse pulmonaire partielle</TO>
<SO>Annales de Chirurgie thoracique et cardio-vasculaire</SO>
<YR>1991</YR>
<VL>45</VL>
<PG>719-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wurtz-1992" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wurtz 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wurtz A, Gambiez L, Chambon JP, Saudemont A</AU>
<TI>Assessement of effectiveness of a fibrin sealant in wedge lung resections. Results of a controlled trial including 50 patients</TI>
<TO>Evaluation de l'efficacité d'une colle de fibrine en chirurgie d'exérèse pulmonaire partielle. Résultats d'un nouvel essai contrôlé chez 50 malades.</TO>
<SO>Lyon Chirurgical</SO>
<YR>1992</YR>
<VL>88</VL>
<PG>368-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Brega-Massone-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Brega Massone 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brega Massone PP, Magnani B, Conti B, Lequaglie C, Cataldo I</AU>
<TI>Cauterization versus fibrin glue for aerostasis in precision resections for secondary lung tumors</TI>
<SO>Annals of Surgical Oncology</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>4</NO>
<PG>441-6</PG>
<IDENTIFIERS MODIFIED="2009-08-19 13:02:46 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gagarine-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Gagarine 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gagarine A, Urschel JD, Miller JD, Bennett WF, Young JE</AU>
<TI>Effect of fibrin glue on air leak and length of hospital stay after pulmonary lobectomy</TI>
<SO>Journal of Cardiovascular Surgery</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>6</NO>
<PG>771-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grunenwald--1989" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Grunenwald  1989" YEAR="1989">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grunenwald D</AU>
<TI>Intraoperative use of fibrin sealant in pulmonary surgery. A prospective study on a series of 124 procedures</TI>
<SO>Annales de Chirurgie</SO>
<YR>1989</YR>
<VL>43</VL>
<NO>2</NO>
<PG>147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gundogdu-2006" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Gundogdu 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gundogdu AG, Yazicioglu A, Kara M, Kanbak M, Dogan R</AU>
<TI>The use of tissue glue and its effect on hospital cost in patients undergoing pulmonary surgery</TI>
<SO>Tuberkuloz ve Toraks</SO>
<YR>2006</YR>
<VL>54</VL>
<NO>2</NO>
<PG>157-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-08-19 11:55:16 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-08-19 11:55:16 +0200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ito-2003" MODIFIED="2009-08-19 14:12:27 +0200" MODIFIED_BY="[Empty name]" NAME="Ito 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-08-19 14:12:27 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ito H, Nakayama H, Arai H, Karita S, Shotsu A, Fujita A</AU>
<TI>Prevention of parenchymal air leakage after lung resection; comparison of effectiveness in drug formation of fibrin adhesive</TI>
<SO>Kyobu Geka</SO>
<YR>2003</YR>
<VL>56</VL>
<NO>12</NO>
<PG>1014-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Izbiki-1994" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Izbiki 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Izbicki JR, Kreusser T, Meier M, Prenzel KL, Knoefel WT, Passlick B et al</AU>
<TI>Fibrin-glue-coated collagen fleece in lung surgery--experimental comparison with infrared coagulation and clinical experience</TI>
<SO>Thoracic and Cardiovascular Surgeon</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>5</NO>
<PG>306-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kiaergard-2000" MODIFIED="2009-08-19 14:17:36 +0200" MODIFIED_BY="[Empty name]" NAME="Kiaergard 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-08-19 14:17:36 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard HK, Pedersen JH, Krasnik M, Weis-Fogh US, Fleron H, Griffin HE</AU>
<TI>Prevention of air leakage by spraying vivostat fibrin sealant after lung resection in pigs</TI>
<SO>Chest</SO>
<YR>2000</YR>
<VL>117</VL>
<NO>4</NO>
<PG>1124-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobayashi-2001" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kobayashi 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobayashi H, Sekine T, Nakamura T, Shimizu Y</AU>
<TI>In vivo evaluation of a new sealant material on a rat lung air leak model</TI>
<SO>Journal of Biomedical Materials Research</SO>
<YR>2001</YR>
<VL>58</VL>
<NO>6</NO>
<PG>658-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massone-2002" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Massone 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massone PP, Lequaglie C, Magnani B, Conti B, Cataldo I</AU>
<TI>Control of aerostasis in pulmonary metastasectomy by precision resection. Standard technique versus fibrin glue modification</TI>
<SO>Chirurgia Italiana</SO>
<YR>2002</YR>
<VL>54</VL>
<NO>4</NO>
<PG>447-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matsumura-2004" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Matsumura 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Potaris K, Mihos P, Gakidis I</AU>
<TI>Experience with an albumin-glutaraldehyde tissue adhesive in sealing air leaks after bullectomy</TI>
<SO>Heart Surgery Forum</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>5</NO>
<PG>429-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCarthy-1988" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="McCarthy 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCarthy PM, Trastek VF, Bell DG, Buttermann GR, Piehler JM, Payne WS et al</AU>
<TI>The effectiveness of fibrin glue sealant for reducing experimental pulmonary air leak</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>2</NO>
<PG>203-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miyamoto-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Miyamoto 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyamoto H, Futagawa T, Wang Z, Yamazaki A, Morio A, Sonobe S et al</AU>
<TI>Fibrin glue and bioabsorbable felt patch for intraoperative intractable air leaks</TI>
<SO>Japanese Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2003</YR>
<VL>51</VL>
<NO>6</NO>
<PG>232-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nomori-2000" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Nomori 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nomori H, Horio H, Suemasu K</AU>
<TI>Mixing collagen with fibrin glue to strengthen the sealing effect for pulmonary air leakage</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2000</YR>
<VL>70</VL>
<NO>5</NO>
<PG>1666-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Omote-1994" MODIFIED="2009-08-19 14:50:24 +0200" MODIFIED_BY="[Empty name]" NAME="Omote 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-08-19 14:50:24 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Omote Y, Kubo Y</AU>
<TI>Effectiveness of fibrin glue in preventing postoperative pulmonary air leakage</TI>
<SO>Kyobu Geka</SO>
<YR>1994</YR>
<VL>47</VL>
<NO>5</NO>
<PG>355-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Potaris-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Potaris 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Potaris K, Mihos P, Gakidis I</AU>
<TI>Experience with an albumin-glutaraldehyde tissue adhesive in sealing air leaks after bullectomy</TI>
<SO>Heart Surgery Forum</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>5</NO>
<PG>429-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ranger-1997" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Ranger 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ranger WR, Halpin D, Sawhney AS, Lyman M, Locicero J</AU>
<TI>Pneumostasis of experimental air leaks with a new photopolymerized synthetic tissue sealant</TI>
<SO>American Surgeon</SO>
<YR>1997</YR>
<VL>63</VL>
<NO>9</NO>
<PG>788-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sabanathan-1993" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Sabanathan 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sabanathan S, Eng J, Richardson J</AU>
<TI>The use of tissue adhesive in pulmonary resections</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1993</YR>
<VL>7</VL>
<NO>12</NO>
<PG>657-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ueda-2007" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Ueda 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ueda K, Tanaka T, Jinbo M, Yagi T, Li TS, Hamano K</AU>
<TI>Sutureless pneumostasis using polyglycolic acid mesh as artificial pleura during  video-assisted major pulmonary resection</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2007</YR>
<VL>84</VL>
<NO>6</NO>
<PG>1858-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-08-19 11:44:39 +0200" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bayfield-1996" MODIFIED="2009-03-03 14:47:55 +0100" MODIFIED_BY="[Empty name]" NAME="Bayfield 1996" TYPE="JOURNAL_ARTICLE">
<AU>Bayfield MS, Spotnitz WD</AU>
<TI>Pulmonary applications, including management of bronchopleural fistula</TI>
<SO>Chest Surgery Clinics of North America</SO>
<YR>1996</YR>
<VL>6</VL>
<PG>6567-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dunn-1999" MODIFIED="2009-03-03 15:00:56 +0100" MODIFIED_BY="[Empty name]" NAME="Dunn 1999" TYPE="JOURNAL_ARTICLE">
<AU>Dunn CJ, Goa KL</AU>
<TI>Fibrin sealant. A review of its use in surgery and endoscopy</TI>
<SO>Drugs</SO>
<YR>1999</YR>
<VL>58</VL>
<PG>863-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duque-1997" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Duque 1997" TYPE="JOURNAL_ARTICLE">
<AU>Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, Heras F and the Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica</AU>
<TI>Early complications in surgical treatment of lung cancer: a prospective, multicenter study</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1997</YR>
<VL>63</VL>
<PG>944-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eng-1989" MODIFIED="2009-10-29 13:55:26 +0100" MODIFIED_BY="[Empty name]" NAME="Eng 1989" TYPE="JOURNAL_ARTICLE">
<AU>Eng J, Sabanathan S</AU>
<TI>Tissue adhesive in bronchial closure</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1989</YR>
<VL>48</VL>
<PG>683-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grunenwald-1989" MODIFIED="2009-03-03 15:07:19 +0100" MODIFIED_BY="[Empty name]" NAME="Grunenwald 1989" TYPE="JOURNAL_ARTICLE">
<AU>Grunenwald D</AU>
<TI>Intraoperative use of fibrin sealant in lung surgery</TI>
<TO>Utilisation per-opératoire de colle de fibrine en chirurgie pulmonaire. Étude prospective portant sur une série de 124 interventions</TO>
<SO>Annales de Chirurgie: Chirurgie Thoracique et Cardio Vasculaire</SO>
<YR>1989</YR>
<VL>43</VL>
<PG>147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-10-13 11:27:46 +0200" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Hanbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]</TI>
<SO>The Cochrane Collaboration</SO>
<YR>2008. Available from www.cochrane-handbook.org</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hollaus-1998" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Hollaus 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hollaus PH, Lax F, Janakiev D, Lucciarini P, Katz E, Kreuzer A, Pridun NS</AU>
<TI>Endoscopic treatment of postoperative bronchopleural fistula: experience with 45 cases</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1998</YR>
<VL>66</VL>
<PG>923-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-1996" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kjaergard 1996" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard HK, Fairbrother JE</AU>
<TI>Controlled clinical studies of fibrin sealant in cardiothoracic surgery: a review</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>727-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matar-1990" MODIFIED="2009-03-03 16:10:49 +0100" MODIFIED_BY="[Empty name]" NAME="Matar 1990" TYPE="JOURNAL_ARTICLE">
<AU>Matar AF, Hill JG, Duncan W, Orfanakis N, Law I</AU>
<TI>Use of biological glue to control pulmonary air leaks</TI>
<SO>Thorax</SO>
<YR>1990</YR>
<VL>45</VL>
<PG>670-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matthew-1990" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Matthew 1990" TYPE="JOURNAL_ARTICLE">
<AU>Matthew TL, Spotnitz WD, Kron IL, Daniel TM, Tribble CG, Nolan SP</AU>
<TI>Four years' experience with fibrin sealant in thoracic and cardiovascular surgery</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1990</YR>
<VL>50</VL>
<PG>40-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyamoto-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Miyamoto 2003" TYPE="JOURNAL_ARTICLE">
<AU>Miyamoto H, Futagawa E, Wang Z, Yamazaki A, Morio A, Sonobe S et al</AU>
<TI>Fibrin glue and bioabsorbable felt patch for intraoperative intractable air leaks</TI>
<SO>Japanese Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2003</YR>
<VL>51</VL>
<PG>232-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mizuno-1995" MODIFIED="2009-03-03 17:19:52 +0100" MODIFIED_BY="[Empty name]" NAME="Mizuno 1995" TYPE="JOURNAL_ARTICLE">
<AU>Mizuno H, Hitomi S, Nakamura T, Shimizu Y</AU>
<TI>Clinical experience of the combined use of polyglycolide non-woven felt with fibrin glue to prevent postoperative pulmonary fistula</TI>
<SO>Journal of the Japanese Association of Thoracic Surgery</SO>
<YR>1995</YR>
<VL>43</VL>
<PG>1559-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nomori-1999" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Nomori 1999" TYPE="JOURNAL_ARTICLE">
<AU>Nomori H, Horio H, Morinaga S, Suemasu K</AU>
<TI>Gelatin-resorcinol-formaldehyd-glutaraldehyde glue for sealing pulmonary air leaks during thoracoscopic operation</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<PG>212-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nomori-2000" MODIFIED="2009-03-03 17:24:31 +0100" MODIFIED_BY="[Empty name]" NAME="Nomori 2000" TYPE="JOURNAL_ARTICLE">
<AU>Nomori H, Horio H, Suemasu K</AU>
<TI>The efficacy and side effects of gelatine-resorcinol-formaldehyde-glutaraldehyde glue for preventing and sealing pulmonary air leakage</TI>
<SO>Surgery Today</SO>
<YR>2000</YR>
<VL>30</VL>
<PG>244-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Otani-1999" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Otani 1999" TYPE="JOURNAL_ARTICLE">
<AU>Otani Y, Tabata Y, Ikada Y</AU>
<TI>Sealing effect of rapidly curable gelatin-poli(L-glutamic acid) hydrogel glue on lung air leak</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<PG>922-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Passage-2005" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Passage 2005" TYPE="JOURNAL_ARTICLE">
<AU>Passage J, Tam R, Windsor M and OBrien M</AU>
<TI>BioGlue: A review of the use of this new surgical adhesive in thoracic surgery</TI>
<SO>ANZ Journal of Surgery</SO>
<YR>2005</YR>
<VL>75</VL>
<PG>315-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Potaris-2003" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Potaris 2003" TYPE="JOURNAL_ARTICLE">
<AU>Potaris K, Mihos P, Gakidis I</AU>
<TI>Experience with an albumin-glutaraldehyde tissue adhesive in sealing air leaks after bullectomy</TI>
<SO>Heart Surgery Forum</SO>
<YR>2003</YR>
<VL>6</VL>
<PG>429-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Radosevich-1997" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Radosevich 1997" TYPE="JOURNAL_ARTICLE">
<AU>Radosevich M, Goubran HI, Burnouf T</AU>
<TI>Fibrin sealant : scientific rationale, production methods, properties, and current clinical use</TI>
<SO>Vox Sanguinis</SO>
<YR>1997</YR>
<VL>72</VL>
<PG>133-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rankin-1986" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Rankin 1986" TYPE="BOOK_SECTION">
<AU>Rankin EM</AU>
<TI>Randomized clinical trials in cancer: A critical review by site</TI>
<SO>Non-small cell lung cancer</SO>
<YR>1986</YR>
<PG>447-92</PG>
<ED>Slevin ML, Staquet MJ</ED>
<PB>Raven Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rice-1992" MODIFIED="2009-10-29 13:42:33 +0100" MODIFIED_BY="[Empty name]" NAME="Rice 1992" TYPE="JOURNAL_ARTICLE">
<AU>Rice T, Kirby T</AU>
<TI>Prolonged air leak</TI>
<SO>Chest Surgery Clinics of North America.</SO>
<YR>1992</YR>
<VL>2</VL>
<PG>803-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sabanathan-1993" MODIFIED="2009-10-29 14:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Sabanathan 1993" TYPE="JOURNAL_ARTICLE">
<AU>Sabanathan S, Eng J, Richardson J</AU>
<TI>The use of tissue adhesive in pulmonary resections</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>657-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Travis-2004" MODIFIED="2009-10-20 11:50:47 +0200" MODIFIED_BY="[Empty name]" NAME="Travis 2004" TYPE="BOOK">
<AU>Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC</AU>
<TI>Pathology and genetics of tumours of the lung, pleura, thymus and heart</TI>
<SO>Lyon</SO>
<YR>2004</YR>
<PG>9-122</PG>
<PB>IARC press</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-World-Cancer-Report-2003" MODIFIED="2009-03-10 13:55:46 +0100" MODIFIED_BY="[Empty name]" NAME="World Cancer Report 2003" TYPE="BOOK_SECTION">
<AU>International Agency for Research on Cancer</AU>
<TI>The Global Burden Of Cancer</TI>
<SO>World Cancer Report</SO>
<YR>2003</YR>
<PG>12</PG>
<ED>Steward BW, Kleihues P</ED>
<PB>IARC Press</PB>
<CY>Lyon</CY>
<IDENTIFIERS MODIFIED="2009-03-10 13:27:53 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wright-1997" MODIFIED="2009-10-29 13:45:51 +0100" MODIFIED_BY="[Empty name]" NAME="Wright 1997" TYPE="JOURNAL_ARTICLE">
<AU>Wright CD, Wain JC, Grillo HC, Moncure AC, Macaluso SM, Mathisen DJ</AU>
<TI>Pulmonary lobectomy patient care pathway: a model to control cost and maintain quality</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1997</YR>
<VL>64</VL>
<PG>299-302</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-10-20 11:34:01 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Cochrane-2001" MODIFIED="2009-10-20 11:33:21 +0200" MODIFIED_BY="[Empty name]" NAME="Cochrane 2001" TYPE="COCHRANE_REVIEW">
<AU>Rami R, Mateu M</AU>
<TI>Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-10-20 11:33:21 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-10-20 11:33:21 +0200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="Art. No.: CD00305. DOI: 0.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cochrane-2005" MODIFIED="2009-10-20 11:34:01 +0200" MODIFIED_BY="[Empty name]" NAME="Cochrane 2005" TYPE="COCHRANE_REVIEW">
<AU>Serra-Mitjans M, Belda-Sanchis J, Rami-Porta R</AU>
<TI>Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2009-10-20 11:34:01 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-10-20 11:34:01 +0200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="Art. No.: CD00305. DOI: 10.1002/14651858 "/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-12-04 09:54:34 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-12-04 09:54:34 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Allen-2004">
<CHAR_METHODS MODIFIED="2009-03-06 12:57:36 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter prospective randomized control study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and sixty-one patients requiring pulmonary resections other than pneumonectomy and decortication. There were 13 patients who did not complete the trial after randomization, 8 patients in the sealant group and 5 patients in the control group. Ninety-five patients were assigned to the sealant group and fifty-three patients to the control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 12:58:14 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard surgical treatment plus polymeric biodegradable sealant. B) Control group: Standard procedures to control air leaks with no addition of sealant</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: proportion of patients who remained air leak free following surgery. Secondary: proportion of intraoperative air leaks in each group that were sealed or reduced, proportion of patients in each group that was free of air leaks immediately following surgery, duration of postoperative air leak, chest tube duration and length of hospitalization</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-20 11:29:31 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized patients only included those that had at least one significant air leak (&#8805; 2.0 mm in size) after pulmonary resection</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anegg-2007">
<CHAR_METHODS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, prospective, open-label, parallel group study carried out at a single center</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and fifty-two patients were randomized. Seventy-seven were assigned to the treatment group. Seventy-five were assigned to standard treatment group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:01:19 +0100" MODIFIED_BY="[Empty name]">
<P>Inteventions  A) Intervention group: parenchymal suturing, stapling or electrocautery plus a collagen patch with human fibrinogen and human thrombin. B) Control group: standard surgical procedure with parenchymal suturing, staplers, and electrocautery with no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: Quantitative measure of postoperative air leaks at days one and two. Secondary: Mean time to chest drain removal, mean time to hospital discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-06 13:02:35 +0100" MODIFIED_BY="[Empty name]">
<P>All the randomized patients had a non-small cell lung cancer. One hundred and forty-eight patients undergoing lobectomy; twenty five undergoing a segmentectomy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Belboul-2004">
<CHAR_METHODS MODIFIED="2009-03-06 13:03:19 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective blinded randomized study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:03:31 +0100" MODIFIED_BY="[Empty name]">
<P>Forty patients undergoing a pulmonary lobectomy. Twenty patients were randomized to the autologous fibrin sealant. Twenty patients were assigned to the control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:03:46 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard surgical lobectomy. Autologous fibrin sealant was applied. B) Control group: Standard lobectomy with no additional interventions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 13:04:04 +0100" MODIFIED_BY="[Empty name]">
<P>Rate of air leak on the day of the operation and daily thereafter until chest drains were removed, time to chest tube removal, 24-h and chest-tube drainage (bleeding/exudation) volume at removal of chest tube, duration of thoracic epidural analgesia treatment and postoperative length of  the hospital stay. All patients had lung tumours limited to one lobe</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>All patients had air leaks before randomization</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Droghetti-2008">
<CHAR_METHODS MODIFIED="2009-03-06 13:04:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, prospective, controlled parallel-group trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:05:35 +0100" MODIFIED_BY="[Empty name]">
<P>Forty patients were randomized. Twenty were assigned to the treatment group. Twenty were assigned to standard treatment group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:05:37 +0100" MODIFIED_BY="[Empty name]">
<P>Interventions A) Intervention group: electrocautery surgical dissection of interlobar fissures plus a collagen patch with human fibrinogen and human thrombin. B) Control group: routine surgical procedure with staplers with no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: Percentage of demonstrated intraoperative alveolar air leak effectively sealed after application of the sealant and to compare the proportion of patients in the sealant and control groups who were free of air leaks throughout hospitalization. Secondary: Postoperative air leaks, the moment of chest tube removal, length of hospitalization. Costs of the procedure and hospitalization, safety of the sealant treatment by surveillance of the incidence and severity of complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>All the randomized patients had early-stage non-small cell lung cancer. This was a pilot study, and no attempts were made to calculate a sample size to provide statistical power sufficient for confident evaluation of the results.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-06 20:37:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fabian-2003">
<CHAR_METHODS MODIFIED="2009-03-06 20:37:54 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective randomized blinded study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:07:36 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and thirteen patients undergoing planned open anatomic resection or wedge resection. Thirteen were withdrawn intraoperatively. The remaining 100 patients were randomized. Fifty patients were assigned to treatment group and 50 to control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:07:50 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: At the end of the procedure patients were treated with an application of fibrin glue. B) Control Group: received no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 13:08:06 +0100" MODIFIED_BY="[Empty name]">
<P>The incidence and duration of air leaks, prolonged alveolar air leaks, the volume of pleural drainage, the time to tube removal and the postoperative length of stay and any complications related to treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fleisher-1990">
<CHAR_METHODS MODIFIED="2009-03-06 13:29:13 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:29:28 +0100" MODIFIED_BY="[Empty name]">
<P>Twenty-eight patients undergoing uncomplicated lobectomy. Fourteen (9 male and 5 female with a mean age of 63.8 years) were included in the fibrin group. Fourteen (8 male and 6 female of 59.0 years of mean age) were controls</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:29:45 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: Division of lung fissures with stapling devices; two millilitres of fibrin glue were applied to staple lines and any cut surfaces of the lung regardless of the presence or absence of air leaks. B) Control group: Division of lung fissures with stapling devices, without additional fibrin glue</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Duration of postoperative air leaks, chest tube drainage and postoperative hospitalization</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-06 13:30:07 +0100" MODIFIED_BY="[Empty name]">
<P>Patients were randomized by their hospital record number</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lang-2003">
<CHAR_METHODS MODIFIED="2009-03-06 13:30:44 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter randomized and prospective study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and eighty-nine patients undergoing lobectomy or bilobectomy for lung cancer were enrolled in this trial. Ninety-six patients were assigned to treatment group and 93 to control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:31:21 +0100" MODIFIED_BY="[Empty name]">
<P>A) Treatment group: standard surgical resection plus absorbable patch consisting of an equine-collagen fleece coated with human fibrinogen and human thrombin. B) Control Group: Surgical standard procedures with no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 13:31:36 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: incidence of air leakage 48 h after lobectomy. Secondary: reduction of intraoperative air leakage intensity after the first test treatment, intensity and duration of postoperative air leakage up to postoperative day 9, postoperative mortality and morbidity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Macchiarini-1999">
<CHAR_METHODS MODIFIED="2009-03-06 13:32:03 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Thirty patients requiring pulmonary resection other than pneumonectomy. Four were ineligible because they eventually required pneumonectomy. Two were pilot patients. Thirteen (9 male and 4 female of 61 years mean age) were assigned to the treatment group. Eleven (9 male and 2 female of 59 years mean age) were controls</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:32:27 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard bronchial closure and suture; a synthetic sealant was applied to all identified surgical sites (staple lines, suture lines, areas of dissection or adhesiolysis), excluding bronchial stump, regardless of the presence of air leaks. Additional sealant was applied if leaks persisted or new leaks were identified. B) Control group: standard bronchial closure and suture, with no addition of sealant</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: persistence of air leaks during operation and duration of chest tube air leaks. Secondary: time from operation to chest tube removal and hospital discharge, hospitalization time and costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marta-2008">
<CHAR_METHODS MODIFIED="2009-03-06 13:33:33 +0100" MODIFIED_BY="[Empty name]">
<P>Open, randomized, prospective, multicenter, parallel-group trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:33:46 +0100" MODIFIED_BY="[Empty name]">
<P>Three hundred and one patients requiring pulmonary lobectomy. One hundred and forty-nine were assigned to the treatment group. One hundred and fifty were assigned to standard treatment group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:34:01 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard surgical resection plus absorbable patch consisting of human fibrinogen and human thrombin. B) Control group: surgical standard procedures with no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: Duration of postoperative air leak. Secondary: reduction of intraoperative air leakage intensity after treatment, number of days after removal of last chest tubes, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-06 13:34:24 +0100" MODIFIED_BY="[Empty name]">
<P>All patients randomized had lung cancer. Only patients with grade one or two air leakage evaluated by water submersion test were randomized</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-06 13:35:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mouritzen-1993">
<CHAR_METHODS MODIFIED="2009-03-06 13:34:58 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 13:35:11 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and fifteen patients undergoing pulmonary resections including pneumonectomy. One patient was withdrawn because more than one surgical procedure was required. Fifty-five were assigned to the fibrin glue group and 59 to the control group. Seventy-seven patients were male and 37 female; their mean age was 59 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:35:21 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard surgical treatment; fibrin glue was applied to bronchial stumps and lung surfaces. B) Control group: standard surgical treatment with no additional fibrin glue</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 13:35:37 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: difference in air-tolerance-pressure before and after fibrin glueing; rate of patients with postoperative bronchopleural or pulmonary leakages; number of days with persistent air leakage, only for patients who presented an air leak on the first postoperative day. Secondary: length of stay in the intensive care unit; length of hospital stay; duration of intubation after surgery; number of days with chest tubes; rate of complications; daily amount of secretion from chest tubes; general condition of the patient</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porte-2001">
<CHAR_METHODS MODIFIED="2009-03-06 13:36:08 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and twenty four patients requiring pulmonary lobectomy or bilobectomy. Four patients were withdrawn because they died. Fifty-nine patients were assigned to the treatment group. Sixty-one patients were controls</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 13:36:29 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: A synthetic sealant was applied to all identified surgical sites leaking air or at risk of leaking air. B) Control group: After standard surgical treatment patients underwent no further procedures</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 13:36:44 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: Safety of surgical lung sealant by surveillance for unexpected adverse events during follow-up. Secondary: percentage of alveolar air leaks effectively sealed at operation after sealant application, durability of alveolar air leaks sealing and potential effect of sealant on the in-hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-06 13:36:55 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized patients only included those judged intraoperatively to have moderate to severe alveolar air leaks</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-12 18:25:36 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tansley-2006">
<CHAR_METHODS MODIFIED="2009-03-06 13:37:30 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective, randomized, single-blind, controlled study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 14:11:36 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty-two patients were randomized. Twenty-five were assigned to the treatment arm. Twenty-seven were assigned to the non-interventional arm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 14:11:48 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: parenchymal suturing or stapling plus a mixture of bovine serum albumin and glutaraldehyde. B) Control group: standard surgical procedure (parenchymal suturing and stapling) with no additional treatments</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-12 18:25:36 +0200" MODIFIED_BY="[Empty name]">
<P>Primary: Duration of air leak, duration of intercostal drainage, and duration of hospital stay. Secondary: Postoperative complications other than air leaks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wain-2001">
<CHAR_METHODS MODIFIED="2009-03-06 18:20:09 +0100" MODIFIED_BY="[Empty name]">
<P> Randomized controlled clinical study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>One hundred and eighty patients undergoing lobectomy, wedge and segmental resections by open thoracotomy. Eight patients were excluded because they were pilot patients. One hundred and seventeen were assigned to the treatment group. Fifty-five patients were assigned to the control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 18:20:41 +0100" MODIFIED_BY="[Empty name]">
<P>A) Interventional group: Standard surgical treatment ; a synthetic sealant (Focal Seal) was applied to all sites of surgical manipulation. B) Control group: standard surgical treatment with no additional fibrin glue</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: Percentage of patients free of air leakage throughout hospitalization. Secondary: control of air leaks intraoperatively, time to postoperative air leak cessation, time to chest tube removal, time to hospital discharge and safety outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-06 18:22:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wong-1997">
<CHAR_METHODS MODIFIED="2009-03-06 18:21:22 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 18:21:38 +0100" MODIFIED_BY="[Empty name]">
<P>Sixty-six patients undergoing lobectomy segmentectomy or decortication, and presented moderate to severe alveolar air leaks after treating it with measures such as suturing or electrocautering. Thirty-three (22 male and 11 female of 62 years of median age) were assigned to the control group. Thirty-three (24 male and 9 female of 55.3 years of median age) were assigned to the fibrin glue group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 18:21:52 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: standard procedures to control air leaks; fibrin glue was applied to leaking areas while ventilation was suspended for a maximum of 2 minutes. B) Control group: Standard procedures to control air leaks with no additional fibrin glue</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-06 18:22:03 +0100" MODIFIED_BY="[Empty name]">
<P>Days of postoperative air leaks, days of intercostal drainage, and of in-hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wurtz-1990">
<CHAR_METHODS MODIFIED="2009-03-06 18:22:38 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective randomized study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 18:22:49 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty patients undergoing a pulmonary resection except pneumonectomy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 18:24:51 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: at the end of the procedure patients were treated with fibrin glue. B) Control group: No additional interventions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Quality of aerostasis, post-operative drainage, persistence of residual collection or faulty re-expansion after removal of drains, the necessity for repeated drainage and length of post-operative hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wurtz-1992">
<CHAR_METHODS MODIFIED="2009-03-06 18:23:50 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective randomized study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-06 18:24:03 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty patients undergoing a pulmonary resection except pneumonectomy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-06 18:24:36 +0100" MODIFIED_BY="[Empty name]">
<P>A) Intervention group: at the end of the procedure patients were treated with fibrin glue. B) Control group: No additional interventions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Post-operative amount of drainage, persistence of residual collection or faulty re-expansion after removal of drains and length of post-operative hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-08-19 12:47:24 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:14:42 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brega-Massone-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:14:42 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:10:09 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gagarine-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:10:09 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:07:11 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grunenwald--1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:07:11 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:45:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gundogdu-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:45:10 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:45:26 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ito-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:45:26 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:13:19 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Izbiki-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:13:19 +0200" MODIFIED_BY="[Empty name]">
<P>Animal case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:09:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kiaergard-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:09:10 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:20:01 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kobayashi-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:20:01 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study in rats</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:15:40 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Massone-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:15:40 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:20:40 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matsumura-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:20:40 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:37:32 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McCarthy-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:37:32 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:13:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyamoto-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:13:10 +0200" MODIFIED_BY="[Empty name]">
<P>Clinical case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:21:44 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nomori-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:21:44 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:36:12 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Omote-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:36:12 +0200" MODIFIED_BY="[Empty name]">
<P>Non-randomized comparative study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:05:32 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Potaris-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:05:32 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:42:14 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ranger-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:42:14 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized animal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:47:24 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sabanathan-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:47:24 +0200" MODIFIED_BY="[Empty name]">
<P>Clinical case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-19 12:03:26 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ueda-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-19 12:03:26 +0200" MODIFIED_BY="[Empty name]">
<P>Case control study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-08-19 11:44:39 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-12-04 09:54:34 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-12-04 09:54:34 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-17 17:59:27 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Allen-2004">
<DESCRIPTION>
<P>Insufficient information about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:48:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anegg-2007">
<DESCRIPTION>
<P>Quote: "Randomisation, on the basis of the use of close envelopes containing notes reading either &#8216;A&#8217; for Tachosil<SUP>®</SUP> or &#8216;B&#8217; for conventional treatment, was performed intraoperatively...".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-26 19:58:22 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belboul-2004">
<DESCRIPTION>
<P>Quote: "The patients were assigned to either the control or Vivostat groups by opening a sealed envelope that contained the randomisation code (allocated by a computer general random sequence)".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:49:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Droghetti-2008">
<DESCRIPTION>
<P>Quote: "Randomization was performed intraoperatively using closed envelopes containing notes reading either &#8216;&#8216;ES&#8217;&#8217; for electrocautery and sealant or &#8216;&#8216;ST&#8217;&#8217; for conventional treatment with staplers".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:50:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fabian-2003">
<DESCRIPTION>
<P>Quote: "Patients were randomly assigned in the operating room to control or treatment groups in a 1:1 ratio by opening a sealed envelop" </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 11:45:02 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fleisher-1990">
<DESCRIPTION>
<P>Sequence was generated by their hospital record number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lang-2003">
<DESCRIPTION>
<P>Insufficient information about the sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:51:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macchiarini-1999">
<DESCRIPTION>
<P>Quote: "the randomization for each patient was maintained in a sealed envelope"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marta-2008">
<DESCRIPTION>
<P>Quote: "patients were randomized by means of an interactive voice response system"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:52:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mouritzen-1993">
<DESCRIPTION>
<P>Patients were randomized by a close-envelope system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-20 11:44:20 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porte-2001">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:52:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansley-2006">
<DESCRIPTION>
<P>Quote: "Randomization was undertaken with sequential closed envelopes..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:54:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wain-2001">
<DESCRIPTION>
<P>Quote: "The patients were then randomized within their risk stratum by opening one or two sealed envelopes.The envelopes were randomly sequenced by computer"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:54:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1997">
<DESCRIPTION>
<P>Quote: "Patients were randomized by a close envelope"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 14:20:33 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wurtz-1990">
<DESCRIPTION>
<P>Sequence generation was made by the method of coin tossing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 14:25:37 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wurtz-1992">
<DESCRIPTION>
<P>Sequence generation was made by the method of coin tossing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-12-04 09:54:17 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-17 17:58:20 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Allen-2004">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:46:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Anegg-2007">
<DESCRIPTION>
<P>Quote: "Randomisation, on the basis of the use of close envelopes..." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belboul-2004">
<DESCRIPTION>
<P>The patients were randomized intraoperatively by opening a sealed envelope. Investigators enrolling patients could not foresee assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:48:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Droghetti-2008">
<DESCRIPTION>
<P>Randomization was performed using closed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:50:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fabian-2003">
<DESCRIPTION>
<P>Randomization was done by opening a sealed envelop</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 13:32:32 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fleisher-1990">
<DESCRIPTION>
<P>Assignement of either group was made before thoracotomy by the surgeon according the hospital record number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 12:12:25 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lang-2003">
<DESCRIPTION>
<P>There is not sufficient information about the allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 12:34:42 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macchiarini-1999">
<DESCRIPTION>
<P>Quote: "The envelopes were sequentially opened"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marta-2008">
<DESCRIPTION>
<P>Insufficient information about the allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-18 00:50:34 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mouritzen-1993">
<DESCRIPTION>
<P>Closed envelopes were sequentially opened after pulmonary resection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 13:25:22 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porte-2001">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-16 14:00:00 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansley-2006">
<DESCRIPTION>
<P>Close envelopes were opened sequentially</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-04 09:54:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wain-2001">
<DESCRIPTION>
<P>Quote: "The patients were then randomized within their risk stratum by opening one or two sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-18 00:51:18 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1997">
<DESCRIPTION>
<P>A closed envelope was opened after lung resection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wurtz-1990">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wurtz-1992">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-26 12:42:51 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Allen-2004">
<DESCRIPTION>
<P>Quote: "Postoperative air leaks were assessed by qualified hospital staff, including investigators..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-10-20 11:43:20 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Anegg-2007">
<DESCRIPTION>
<P>Postoperative air leakage volume measurements were made by the investigators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-26 20:44:24 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belboul-2004">
<DESCRIPTION>
<P>Quote: "The personnel recording these parameters were blinded to the intervention received".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 10:34:47 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Droghetti-2008">
<DESCRIPTION>
<P>The study did not address this outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-10-18 00:34:13 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fabian-2003">
<DESCRIPTION>
<P>The presence or absence of air leak and the volume of chest tube drainage were assessed by a blinded observer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 11:59:41 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fleisher-1990">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 12:14:45 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lang-2003">
<DESCRIPTION>
<P>The study did not address this outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 12:35:09 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macchiarini-1999">
<DESCRIPTION>
<P>The study did not address this outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 13:03:40 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marta-2008">
<DESCRIPTION>
<P>The study did not address this outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mouritzen-1993">
<DESCRIPTION>
<P>Insufficient information about this item</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 13:25:27 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porte-2001">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansley-2006">
<DESCRIPTION>
<P>Insufficient information about this item</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 14:10:59 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wain-2001">
<DESCRIPTION>
<P>Quote: "Evaluation and recording of chest tube output was handled by the nursing and physician staff at the bedside who were blinded to the randomization status of the subject"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 14:13:42 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1997">
<DESCRIPTION>
<P>There is not sufficient information about the blinding of participants and outcome assessors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 14:22:06 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wurtz-1990">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-08-16 14:26:06 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wurtz-1992">
<DESCRIPTION>
<P>No information reported about this domain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-12-04 09:44:49 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.03" NO="3">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-10-29 13:47:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Allen-2004">
<DESCRIPTION>
<P>Quote: "patients were followed up at 1 month and questioned about complications since discharge from the hospital". Patients in the two groups who did not complete the trial after randomization are well described. The primary reason patients randomized but excluded of the trial are well described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-10-18 00:35:02 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Anegg-2007">
<DESCRIPTION>
<P>Early and late outcomes were controlled in all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-17 18:09:21 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belboul-2004">
<DESCRIPTION>
<P>Quote: "No patients were withdrawn from the study". </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 10:39:03 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Droghetti-2008">
<DESCRIPTION>
<P>No missing outcome data. Quote: "One and 3 months after surgery the treated patients underwent a clinical examination and chest radiography"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fabian-2003">
<DESCRIPTION>
<P>Excluded patients and outcomes were well reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 12:01:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fleisher-1990">
<DESCRIPTION>
<P>No missing outcome data in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 12:18:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lang-2003">
<DESCRIPTION>
<P>Patients included and excluded are well reported, outcomes were recorded in all patients until a final follow-up control 1 month postoperatively </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 13:55:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macchiarini-1999">
<DESCRIPTION>
<P>No missing outcome data in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-12-04 09:44:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marta-2008">
<DESCRIPTION>
<P>No missing outcome data is reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 13:19:44 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mouritzen-1993">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 13:26:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porte-2001">
<DESCRIPTION>
<P>Outcomes and patients that could not be evaluated according to the study protocol were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 14:00:51 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansley-2006">
<DESCRIPTION>
<P>Criteria of exclusion and outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 14:11:18 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wain-2001">
<DESCRIPTION>
<P>Criteria of exclusion and outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 14:14:12 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1997">
<DESCRIPTION>
<P>Criteria of exclusion and outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-16 14:24:10 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wurtz-1990">
<DESCRIPTION>
<P>Outcome data were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2009-08-17 18:17:20 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wurtz-1992">
<DESCRIPTION>
<P>Outcome data were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2009-10-29 13:47:23 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-03-01 18:18:02 +0100" MODIFIED_BY="[Empty name]"> Randomized studies of sealants in lung surgery</TITLE>
<TABLE COLS="8" ROWS="49">
<TR>
<TD>
<P>Authors</P>
</TD>
<TD>
<P>Sealant</P>
</TD>
<TD>
<P>Nº patients</P>
</TD>
<TD>
<P>Air leaks duration</P>
</TD>
<TD>
<P>Days chest tube</P>
</TD>
<TD>
<P>Prolonged air leaks</P>
</TD>
<TD>
<P>Days hospitalization</P>
</TD>
<TD>
<P>Empyema</P>
</TD>
</TR>
<TR>
<TD>
<P>Fleisher</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment: 14</P>
</TD>
<TD>
<P>3.2</P>
</TD>
<TD>
<P>6.1</P>
</TD>
<TD>
<P>14%*</P>
</TD>
<TD>
<P>9.8</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 14</P>
</TD>
<TD>
<P>3.3</P>
</TD>
<TD>
<P>5.9</P>
</TD>
<TD>
<P>7%</P>
</TD>
<TD>
<P>11.5</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Wong</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment: 33</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 33</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>3%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Mouritzen</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment: 55</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 59</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Macchiarini</P>
</TD>
<TD>
<P>Advaseal</P>
</TD>
<TD>
<P>Treatment: 13</P>
</TD>
<TD>
<P>1.9</P>
</TD>
<TD>
<P>6.1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>13</P>
</TD>
<TD>
<P>3,8%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 11</P>
</TD>
<TD>
<P>2.4</P>
</TD>
<TD>
<P>6.4</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Porte</P>
</TD>
<TD>
<P>Advaseal</P>
</TD>
<TD>
<P>Treatment: 59</P>
</TD>
<TD>
<P>33.7 h</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>13%</P>
</TD>
<TD>
<P>9.2</P>
</TD>
<TD>
<P>6.78%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 61</P>
</TD>
<TD>
<P>63.22 h</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>22%</P>
</TD>
<TD>
<P>8.59</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Wain</P>
</TD>
<TD>
<P>Focal Seal</P>
</TD>
<TD>
<P>Treatment: 117</P>
</TD>
<TD>
<P>30.9 h</P>
</TD>
<TD>
<P>4.5</P>
</TD>
<TD>
<P>2.5%</P>
</TD>
<TD>
<P>7.4</P>
</TD>
<TD>
<P>3%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 55</P>
</TD>
<TD>
<P>52.3 h</P>
</TD>
<TD>
<P>5.2</P>
</TD>
<TD>
<P>7%</P>
</TD>
<TD>
<P>10.1</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Allen</P>
</TD>
<TD>
<P>Bioglue</P>
</TD>
<TD>
<P>Treatment: 95</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>6.8</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 53</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>6.2</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Fabian</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment: 50</P>
</TD>
<TD>
<P>1.1</P>
</TD>
<TD>
<P>3.5</P>
</TD>
<TD>
<P>2%</P>
</TD>
<TD>
<P>4.6</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 50</P>
</TD>
<TD>
<P>3.1</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>16%</P>
</TD>
<TD>
<P>4.9</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Lang</P>
</TD>
<TD>
<P>TachoComb</P>
</TD>
<TD>
<P>Treatment: 96</P>
</TD>
<TD>
<P>1.7</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control: 93</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Belboul</P>
</TD>
<TD>
<P>Vivostat</P>
</TD>
<TD>
<P>Treatment 20</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 20</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>4.5</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Wurtz</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment 25</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>11,4</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 25</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>13</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Wurtz</P>
</TD>
<TD>
<P>Fibrin glue</P>
</TD>
<TD>
<P>Treatment 25</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>9,9</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 25</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>10,6</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Marta</P>
</TD>
<TD>
<P>TachoSil</P>
</TD>
<TD>
<P>Treatment 149</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>4.9</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 150</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>5.5</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Droghetti</P>
</TD>
<TD>
<P>TachoSil</P>
</TD>
<TD>
<P>Treatment 20</P>
</TD>
<TD>
<P>1.7</P>
</TD>
<TD>
<P>7.6</P>
</TD>
<TD>
<P>5%</P>
</TD>
<TD>
<P>14.3</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 20</P>
</TD>
<TD>
<P>3.7</P>
</TD>
<TD>
<P>10.2</P>
</TD>
<TD>
<P>20%</P>
</TD>
<TD>
<P>11.0</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Anegg</P>
</TD>
<TD>
<P>TachoSil</P>
</TD>
<TD>
<P>Treatment 75</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>5.1</P>
</TD>
<TD>
<P>24%</P>
</TD>
<TD>
<P>6.2</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 77</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>6.3</P>
</TD>
<TD>
<P>32.46%</P>
</TD>
<TD>
<P>7.7</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Tansley</P>
</TD>
<TD>
<P>Bio glue</P>
</TD>
<TD>
<P>Treatment 27</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>11%</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Control 25</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>8%</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>0%</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Signif.</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>S</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-10-20 11:15:42 +0200" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2009-10-20 11:15:42 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-10-13 13:55:07 +0200" MODIFIED_BY="[Empty name]">Search strategy for MEDLINE and EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2009-10-20 11:15:42 +0200" MODIFIED_BY="[Empty name]">
<P>MEDLINE</P>
<P>#1 (("Lung Neoplasms"[Mesh] OR "Carcinoma, Small Cell"[Mesh]) OR "Carcinoma, Squamous Cell"[Mesh]) OR "Carcinoma, Non-Small-Cell Lung"[Mesh]</P>
<P>#2 (lung[tiab]) AND (cancer[tiab] OR neoplasm*[tiab] OR adenocarcinoma*[tiab] OR carcinoma*[tiab] OR tumor*[tiab] OR tumour*[tiab] OR squamous[tiab])</P>
<P>#3 (pulmon*[tiab]) AND (cancer[tiab] OR neoplasm*[tiab] OR adenocarcinoma*[tiab] OR carcinoma*[tiab] OR tumor*[tiab] OR tumour*[tiab] OR squamous[tiab])</P>
<P>#4 NSCLC[tiab] OR nonsmall cell lung[tiab] OR non small cell lung[tiab] OR sclc[tiab] OR small cell[tiab]</P>
<P>#5 (((#1) OR (#2)) OR (#3)) OR (#4)</P>
<P>#6 resect*[tiab] OR lobectom*[tiab] OR excision[tiab]</P>
<P>#7 (#5) AND (#6)</P>
<P>#8 Pneumonectomy[mh]</P>
<P>#9 pneumonectom*[tiab]</P>
<P>#10 (pleurectom* OR parietectom* OR segmentectom*).ti,ab.</P>
<P>#11 air leak*[tw]</P>
<P>#12 ((((#7) OR (#8)) OR (#9)) OR (#10)) OR (#11)</P>
<P>#13 "Suture Techniques"[Mesh]</P>
<P>#14 sutur*[tw] OR closur*[tw] OR stapl*[tw]</P>
<P>#15 Surgery[subheading]</P>
<P>#16 ((#13) OR (#14)) OR (#15)</P>
<P>#17 "Tissue Adhesives"[Mesh] OR "Fibrin Tissue Adhesive"[Mesh]</P>
<P>#18 adhesiv*[tw] OR seal*[tw] OR glue*[tw]</P>
<P>#19 (#17) OR (#18)</P>
<P>#20 (#16) AND (#19)</P>
<P>#21 (#12) AND (#20)</P>
<P>EMBASE</P>
<P> 1  exp Lung Tumor/</P>
<P>2  exp Small Cell Carcinoma/</P>
<P>3  exp Squamous Cell Carcinoma/</P>
<P>4  exp Lung non Small Cell Cancer/</P>
<P>5  (lung adj10 (cancer or neoplasm* or adenocarcinoma* or carcinoma* or tumor* or tumour* or squamous)).ti,ab.</P>
<P>6  (pulmon* adj10 (cancer or neoplasm* or adenocarcinoma* or carcinoma* or tumor* or tumour* or squamous)).ti,ab.</P>
<P>7  (NSCLC or nonsmall cell lung or non small cell lung or sclc or small cell).ti,ab.</P>
<P>8  1 or 2 or 3 or 4 or 5 or 6 or 7</P>
<P>9  (resect* or lobectom* or excision).ti,ab.</P>
<P>10  8 and 9</P>
<P>11  exp Lung Resection/</P>
<P>12  pneumonectom*.ti,ab.</P>
<P>13  (pleurectom* or parietectom* or segmentectom*).ti,ab.</P>
<P>14  air leak*.ti,ab.</P>
<P>15  11 or 13 or 10 or 12 or 14</P>
<P>16  exp Suturing Method/</P>
<P>17  (sutur* or closur* or stapl*).mp.</P>
<P>18  16 or 17</P>
<P>19  exp Tissue Adhesive/</P>
<P>20  exp Fibrin Glue/</P>
<P>21  (adhesiv* or seal* or glue*).tw.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>